BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hassanipour S, Vali M, Gaffari-Fam S, Nikbakht HA, Abdzadeh E, Joukar F, Pourshams A, Shafaghi A, Malakoutikhah M, Arab-Zozani M, Salehiniya H, Mansour-Ghanaei F. The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis. EXCLI J 2020;19:108-30. [PMID: 32038120 DOI: 10.17179/excli2019-1842] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
Number Citing Articles
1 Zhou JL, Huang XY, Qiu HC, Gan RZ, Zhou H, Zhu HQ, Zhang XX, Lu GD, Liang G. SSPH I, a Novel Anti-Cancer Saponin, Inhibits Autophagy and Induces Apoptosis via ROS Accumulation and ERK1/2 Signaling Pathway in Hepatocellular Carcinoma Cells. Onco Targets Ther 2020;13:5979-91. [PMID: 32606806 DOI: 10.2147/OTT.S253234] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Yu L, Wang Z, Mo Z, Zou B, Yang Y, Sun R, Ma W, Yu M, Zhang S, Yu Z. Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy. Acta Pharm Sin B 2021;11:2004-15. [PMID: 34386334 DOI: 10.1016/j.apsb.2021.02.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 31.0] [Reference Citation Analysis]
3 Sulaiman AS, Gani RA, Hasan I, Lesmana CRA, Kurniawan J, Jasirwan COM, Kalista KF, Nababan SHH, Aprilicia G, Lesmana LA. Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia. J Gastrointest Cancer 2021. [PMID: 34379264 DOI: 10.1007/s12029-021-00676-0] [Reference Citation Analysis]
4 Alizadeh A, Mansour-Ghanaei F, Bagheri FB, Froutan H, Froutan Y, Joukar F, Atrkar-Roushan Z, Chavoshi SA, Hassanipour S. Imaging Accuracy in Diagnosis of Different Focal Liver Lesions: A Retrospective Study in North of Iran. J Gastrointest Cancer 2021;52:970-5. [PMID: 32929681 DOI: 10.1007/s12029-020-00510-z] [Reference Citation Analysis]
5 Ho YJ, Chang J, Yeh KT, Gong Z, Lin YM, Lu JW. Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma. In Vivo 2020;34:2631-40. [PMID: 32871793 DOI: 10.21873/invivo.12081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen JG, Zhu J, Zhang YH, Chen YS, Ding LL, Chen HZ, Shen AG, Wang GR. Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases. J Hepatocell Carcinoma 2021;8:1023-34. [PMID: 34513745 DOI: 10.2147/JHC.S321346] [Reference Citation Analysis]
7 Liu Z, Liu X, Liang J, Liu Y, Hou X, Zhang M, Li Y, Jiang X. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects. Front Immunol 2021;12:765101. [PMID: 34675942 DOI: 10.3389/fimmu.2021.765101] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ma Z, Li Z, Wang S, Zhou Q, Ma Z, Liu C, Huang B, Zheng Z, Yang L, Zou Y, Zhang C, Huang S, Hou B. SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:899-912. [PMID: 34395329 DOI: 10.2147/JHC.S320326] [Reference Citation Analysis]
9 Chan MH, Lu CN, Chung YL, Chang YC, Li CH, Chen CL, Wei DH, Hsiao M. Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatment. J Nanobiotechnology 2021;19:308. [PMID: 34627267 DOI: 10.1186/s12951-021-01052-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mansour-Ghanaei F, Joukar F, Naghipour M, Hassanipour S, Yeganeh S, Sepehrimanesh M, Fathalipour M. Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS). BMC Res Notes 2021;14:59. [PMID: 33568187 DOI: 10.1186/s13104-021-05474-2] [Reference Citation Analysis]